Stay updated on Pediatric CLN2 Disease Clinical Trial

Sign up to get notified when there's something new on the Pediatric CLN2 Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pediatric CLN2 Disease Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T13:29:28.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Added disease-related MeSH terms (Neuronal ceroid lipofuscinosis type 2, Juvenile NCL, Late-infantile NCL) and a Resources link to Genetic and Rare Diseases Information Center. These elements provide additional context and navigation without altering core trial details.
    Difference
    0.3%
    Check dated 2026-03-28T03:15:32.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T00:55:59.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 across the site.
    Difference
    0.1%
    Check dated 2026-03-06T18:39:06.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1, updating an internal label without affecting the study details or site navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:33:58.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-05T14:19:23.000Z thumbnail image

Stay in the know with updates to Pediatric CLN2 Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pediatric CLN2 Disease Clinical Trial page.